Elekta AB (publ) (STO: EKTA.B)
Market Cap | 26.78B |
Revenue (ttm) | 18.12B |
Net Income (ttm) | 1.13B |
Shares Out | 382.08M |
EPS (ttm) | 2.97 |
PE Ratio | 23.62 |
Forward PE | 13.94 |
Dividend | 2.40 (3.46%) |
Ex-Dividend Date | Sep 6, 2024 |
Volume | 1,449,561 |
Open | 69.25 |
Previous Close | 69.30 |
Day's Range | 69.10 - 70.80 |
52-Week Range | 61.45 - 90.00 |
Beta | 1.12 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Aug 28, 2024 |
About Elekta AB
Elekta AB (publ), a medical technology company, engages in the provision of clinical solutions for treating cancer and brain disorders worldwide. The company offers radiation therapy products, including Elekta Unity for real-time MR visualization; Elekta Versa HD, a brain metastases solution; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; and quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, suc... [Read more]
Financial Performance
In 2024, Elekta AB's revenue was 18.12 billion, an increase of 7.41% compared to the previous year's 16.87 billion. Earnings were 1.30 billion, an increase of 38.07%.
Financial StatementsNews
Elekta AB reports Q1 results
Elekta AB (publ) (EKTAF) Q1 2025 Earnings Call Transcript
![](https://cdn.snapi.dev/images/v1/z/e/press4-2081123.jpg)
ZAP Surgical Deals Two More Blows to Elekta in IP Suit, Removing Barriers to Mass Adoption of the ZAP-X Radiosurgery Platform
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, has achieved significant legal victories in its ongoing patent litigation agains...
![](https://cdn.snapi.dev/images/v1/9/f/press8-1922331.jpg)
St George's Cancer Care Centre Becomes First Elekta Unity Site to Integrate ClearCalc
NEW YORK & CHRISTCHURCH, New Zealand--(BUSINESS WIRE)--St George's Cancer Care Centre is the first cancer center in the world to leverage ClearCalc from Radformation with Elekta's MR-Linac technology.
![](https://cdn.snapi.dev/images/v1/p/r/press9-1248345.jpg)
Elekta: Interim report, May-January 2021/22
STOCKHOLM, Feb. 24, 2022 /PRNewswire/ -- The demand for Elekta's solutions continued to be strong in the third quarter, the fifth consecutive quarter with underlying order growth, resulting in Elekta'...
![](https://cdn.snapi.dev/images/v1/p/r/press18-1231893.jpg)
Elekta announces preliminary third quarter results
STOCKHOLM, Feb. 14, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) today published preliminary financial results for the third quarter 2021/22. The demand for Elekta's precision radiation medicine solutions ...
![](https://cdn.snapi.dev/images/v1/p/r/press16-1218159.jpg)
Invitation to the presentation of Elekta's third quarter 2021/22
STOCKHOLM, Feb. 4, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the third quarter 2021/22 at 10:00 a.m. CET on February 24.
![](https://cdn.snapi.dev/images/v1/p/r/press9-1213238.jpg)
Elekta increases customer focus with direct presence in Philippines
STOCKHOLM, Feb. 2, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has established an office in the Philippines' capital, Manila, to offer new and existing customers superior service, ...
![](https://cdn.snapi.dev/images/v1/p/r/press16-1176211.jpg)
Elekta to appoint Tobias Hägglöv as Chief Financial Officer
STOCKHOLM, Jan. 7, 2022 /PRNewswire/ -- Elekta (STO: EKTA-B) announced today that it will appoint Tobias Hägglöv as Chief Financial Officer effective February 1, 2022, taking over from Johan Adebäck. ...
![](https://cdn.snapi.dev/images/v1/p/r/press5-1134819.jpg)
Elekta's new sustainability-linked bond oversubscribed
STOCKHOLM, Dec. 3, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has issued SEK 1.5 billion senior unsecured sustainability-linked bonds under its Medium Term Note Program (MTN-Progr...
![](https://cdn.snapi.dev/images/v1/p/r/press10-1124177.jpg)
More cancer patients in Africa to benefit from advanced radiation therapy with Elekta Unity MR-Linac
STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCESS 2...
![](https://cdn.snapi.dev/images/v1/p/r/press7-1124175.jpg)
Elekta: Interim report, May-October 2021/22
STOCKHOLM, Nov. 25, 2021 /PRNewswire/ -- The increasing need for investments in cancer care and radiotherapy across the globe supported a gradual market recovery during the quarter. Our orders grew wi...
![](https://cdn.snapi.dev/images/v1/p/r/press11-1087285.jpg)
Invitation to the presentation of Elekta's second quarter 2021/22
STOCKHOLM, Nov. 4, 2021 /PRNewswire/ --Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2021/22 at 10:00 a.m. CET on November 25.
![](https://cdn.snapi.dev/images/v1/p/r/press8-1077166.jpg)
Elekta establishes a framework for sustainability-linked bonds
STOCKHOLM, Oct. 29, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has established a Sustainability-Linked Bond Framework (SLB Framework) for issues of sustainability-linked bonds und...
![](https://cdn.snapi.dev/images/v1/p/r/press5-1067534.jpg)
Elekta receives initial investment grade rating from S&P Global Ratings
STOCKHOLM, Oct. 26, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has received an investment grade (IG) rating from S&P Global Ratings (S&P). S&P has assigned a BBB- rating to Elekta...
![](https://cdn.snapi.dev/images/v1/p/r/press8-990994.jpg)
Elekta acquires Turkish distributor to strengthen market position
STOCKHOLM, Sept. 2, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it has acquired its long-time partner and Turkish distributor of neurosurgery solutions, Özyürek Mümessillik ve Dış Tic...
![](https://cdn.snapi.dev/images/v1/p/r/press7-981226.jpg)
Elekta's Board announces establishment of philanthropic Elekta Foundation
STOCKHOLM, Aug. 26, 2021 /PRNewswire/ -- At its Annual General Meeting on August 25, Elekta's (EKTA-B.ST) shareholders approved the Board of Directors' proposal to establish the Elekta Foundation. The...
![](https://cdn.snapi.dev/images/v1/p/r/press17-979694.jpg)
Report from the Annual General Meeting 2021 in Elekta
STOCKHOLM, Aug. 25, 2021 /PRNewswire/ -- Elekta AB (publ) has held its Annual General Meeting on 25 August 2021. In light of the extraordinary situation prevailing as a result of Covid-19, the Meeting...
![](https://cdn.snapi.dev/images/v1/p/r/press1-979216.jpg)
Elekta to address Indonesia's cancer care gap with direct presence
STOCKHOLM, Aug. 25, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that is has established permanent legal entity in Indonesia's capital, Jakarta in order to address the unmet need for high q...
![](https://cdn.snapi.dev/images/v1/p/r/press7-958984.jpg)
Invitation to the presentation of Elekta's first quarter 2021/22
STOCKHOLM, Aug. 11, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the first quarter 2021/22 at 10:00 a.m. CEST on August 25.
![](https://cdn.snapi.dev/images/v1/p/r/press1-922188.jpg)
Data from 14 leading cancer centers presented at AAPM highlight global adoption of Elekta Unity MR-Linac
ATLANTA, July 23, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced the presentation of 36 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Unity MR-Linac. T...
![](https://cdn.snapi.dev/images/v1/p/r/press10-916985.jpg)
Notice to the Annual General Meeting of Elekta AB (publ)
STOCKHOLM, July 21, 2021 /PRNewswire/ -- The shareholders of Elekta AB (publ), reg. no 556170-4015 are hereby convened to the Annual General Meeting to be held on Wednesday 25 August 2021.
![](https://cdn.snapi.dev/images/v1/p/r/press15-896476.jpg)
Elekta optimizes treatment times for cancer patients via proactive service innovation
STOCKHOLM, July 7, 2021 /PRNewswire/ -- For the last several years, Elekta (EKTA-B.ST) has invested substantially in digitized service solutions to keep critical treatment machines up and running at c...
![](https://cdn.snapi.dev/images/v1/p/r/press13-872113.jpg)
Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients
ATLANTA, June 17, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that its Elekta Harmony* radiation therapy system recently received U.S. FDA 510(k) clearance, paving the way for U.S. clinics...
![](https://cdn.snapi.dev/images/v1/p/r/press6-857026.jpg)
Elekta's new strategy to focus on growth and access to radiation therapy
STOCKHOLM, June 7, 2021 /PRNewswire/ -- At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, Gustaf Salford, and members from his executive management team introduced the company's mid-term strategy, cal...